Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.39
+0.43 (4.80%)
At close: Mar 9, 2026, 4:00 PM EDT
9.35
-0.04 (-0.43%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Kura Oncology Employees
Kura Oncology had 192 employees as of December 31, 2024. The number of employees increased by 50 or 35.21% compared to the previous year.
Employees
192
Change (1Y)
50
Growth (1Y)
35.21%
Revenue / Employee
$351,469
Profits / Employee
-$1,451,385
Market Cap
829.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| Xencor | 260 |
| Arvinas | 246 |
| Omeros | 202 |
| CytomX Therapeutics | 121 |
| Janux Therapeutics | 109 |
| Annexon | 99 |
| Bright Minds Biosciences | 26 |
KURA News
- 3 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 11 days ago - Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 12 days ago - Kura Oncology to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy - Seeking Alpha
- 2 months ago - Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones - GlobeNewsWire
- 3 months ago - Kura Oncology, Inc. (KURA) Discusses Ziftomenib Combination Data in Newly Diagnosed and Relapsed/Refractory NPM1-m and KMT2A-r AML Transcript - Seeking Alpha